Company Email Format Management

Scenic Biotech

Biotechnology Research Science Park 301 38 employees

Employees: 38
Contacts: 3
Emails: 3
Phones: 1

scenicbiotech.com LinkedIn Crunchbase

Scenic Biotech Overview

Headquarters: Science Park 301
Website: scenicbiotech.com
Industry: Biotechnology Research
Employees: 38
Founded: 2017
Funding: 31.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Medicine Rare disease Science Technology Pharmaceuticals Biology Biotechnology Orphan Disease Neurological Disease Metabolic Disease Drug Discovery Drug Development

About Scenic Biotech

Scenic Biotech is advancing modifier therapy, a radically new approach to treating genetic disorders. Instead of targeting the primary disease-causing mutation, modifier therapy seeks to rebalance health by acting on another function in the genome that can neutralize the disease impact, leading to a therapeutic effect. Our robust pipeline, derived from our proprietary Cell-seq™️ platform, includes first-in-class small molecule programs that are either wholly owned or partnered through strategic collaborations with multinational pharmaceutical leaders. By unlocking new pathways in the genome, Scenic will develop a range of modifier therapies to help patients.

Scenic Biotech Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Scenic Biotech Org Chart

Sample employees and titles

Name	Title	Location	Contact
Alexander Vos	Managing Director Biotech Mountains		View
Peter Ros	Vice President Finance & Operations	Netherlands	Email
Ben Machielse	Biotech Executive, Board Member	Naples, Florida, United States	Email Phone
Rianne Ellenbroek	Principal at Bgv (Biogeneration	Amsterdam Area, Netherlands	Email